Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes

Guillermo Garcia-Manero; Maria Diez-Campelo; Edo Vellenga; Meagan A. Jacoby; Brayan Merchan; Dimitri Breems; Agostino Cortelezzi; Vadim Doronin; Valle Gomez; Marielle Beckers; Matteo Giovanni Della Porta; Helen Varsos; Liang Xiu; Nikki DeAngelis; Ivo Nnane; Esther Rose; Koen van Eygen

doi:10.1002/ajh.26095

Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes

Guillermo Garcia-Manero, Maria Diez-Campelo, Edo Vellenga, Meagan A. Jacoby, Brayan Merchan, Dimitri Breems, Agostino Cortelezzi, Vadim Doronin, Valle Gomez, Marielle Beckers, Matteo Giovanni Della Porta, Helen Varsos, Liang Xiu, Nikki DeAngelis, Ivo Nnane, Esther Rose, Koen van Eygen

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	E111-E114
Journal	American journal of hematology
Volume	96
Issue number	4
DOIs	https://doi.org/10.1002/ajh.26095
State	Published - Apr 1 2021

Access to Document

10.1002/ajh.26095

Cite this

Garcia-Manero, G., Diez-Campelo, M., Vellenga, E., Jacoby, M. A., Merchan, B., Breems, D., Cortelezzi, A., Doronin, V., Gomez, V., Beckers, M., Della Porta, M. G., Varsos, H., Xiu, L., DeAngelis, N., Nnane, I., Rose, E., & van Eygen, K. (2021). Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes. American journal of hematology, 96(4), E111-E114. https://doi.org/10.1002/ajh.26095

@article{970be92c97f44e74b4058355b110180f,

title = "Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes",

author = "Guillermo Garcia-Manero and Maria Diez-Campelo and Edo Vellenga and Jacoby, {Meagan A.} and Brayan Merchan and Dimitri Breems and Agostino Cortelezzi and Vadim Doronin and Valle Gomez and Marielle Beckers and {Della Porta}, {Matteo Giovanni} and Helen Varsos and Liang Xiu and Nikki DeAngelis and Ivo Nnane and Esther Rose and {van Eygen}, Koen",

note = "Funding Information: Guillermo Garcia‐Manero, Matteo Giovanni Della Porta, Helen Varsos, Liang Xiu, Esther Rose, and Koen van Eygen contributed to study design; Guillermo Garcia‐Manero, Edo Vellenga, Meagan A. Jacoby, Brayan Merchan, Dimitri Breems, Agostino Cortelezzi, Vadim Doronin, Valle Gomez, Marielle Beckers, Matteo Giovanni Della Porta, Helen Varsos, and Esther Rose acquired the data; Guillermo Garcia‐Manero, Maria Diez‐Campelo, Dimitri Breems, Marielle Beckers, Matteo Giovanni Della Porta, Nikki DeAngelis, Ivo Nnane, and ER analyzed or interpreted the data; all authors contributed to drafting and revising the manuscript and approved it for submission. Medical writing support was provided by Grace Wang, PharmD, of MedErgy, and was funded by Janssen Global Services, LLC. Funding Information: This study was supported by Janssen Research & Development. The authors thank the patients who participated in this trial and their family members, and staff at the study sites. The authors thank Maria Krevvata, PhD, of Janssen Research & Development, LLC, for contributions to the study. Medical writing support was provided by Grace Wang, PharmD, of MedErgy, and was funded by Janssen Global Services, LLC.",

year = "2021",

month = apr,

day = "1",

doi = "10.1002/ajh.26095",

language = "English",

volume = "96",

pages = "E111--E114",

journal = "American Journal of Hematology",

issn = "0361-8609",

number = "4",

}

Garcia-Manero, G, Diez-Campelo, M, Vellenga, E, Jacoby, MA, Merchan, B, Breems, D, Cortelezzi, A, Doronin, V, Gomez, V, Beckers, M, Della Porta, MG, Varsos, H, Xiu, L, DeAngelis, N, Nnane, I, Rose, E & van Eygen, K 2021, 'Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes', American journal of hematology, vol. 96, no. 4, pp. E111-E114. https://doi.org/10.1002/ajh.26095

TY - JOUR

T1 - Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes

AU - Garcia-Manero, Guillermo

AU - Diez-Campelo, Maria

AU - Vellenga, Edo

AU - Jacoby, Meagan A.

AU - Merchan, Brayan

AU - Breems, Dimitri

AU - Cortelezzi, Agostino

AU - Doronin, Vadim

AU - Gomez, Valle

AU - Beckers, Marielle

AU - Della Porta, Matteo Giovanni

AU - Varsos, Helen

AU - Xiu, Liang

AU - DeAngelis, Nikki

AU - Nnane, Ivo

AU - Rose, Esther

AU - van Eygen, Koen

N1 - Funding Information: Guillermo Garcia‐Manero, Matteo Giovanni Della Porta, Helen Varsos, Liang Xiu, Esther Rose, and Koen van Eygen contributed to study design; Guillermo Garcia‐Manero, Edo Vellenga, Meagan A. Jacoby, Brayan Merchan, Dimitri Breems, Agostino Cortelezzi, Vadim Doronin, Valle Gomez, Marielle Beckers, Matteo Giovanni Della Porta, Helen Varsos, and Esther Rose acquired the data; Guillermo Garcia‐Manero, Maria Diez‐Campelo, Dimitri Breems, Marielle Beckers, Matteo Giovanni Della Porta, Nikki DeAngelis, Ivo Nnane, and ER analyzed or interpreted the data; all authors contributed to drafting and revising the manuscript and approved it for submission. Medical writing support was provided by Grace Wang, PharmD, of MedErgy, and was funded by Janssen Global Services, LLC. Funding Information: This study was supported by Janssen Research & Development. The authors thank the patients who participated in this trial and their family members, and staff at the study sites. The authors thank Maria Krevvata, PhD, of Janssen Research & Development, LLC, for contributions to the study. Medical writing support was provided by Grace Wang, PharmD, of MedErgy, and was funded by Janssen Global Services, LLC.

PY - 2021/4/1

Y1 - 2021/4/1

UR - http://www.scopus.com/inward/record.url?scp=85100023289&partnerID=8YFLogxK

U2 - 10.1002/ajh.26095

DO - 10.1002/ajh.26095

M3 - Letter

C2 - 33448430

AN - SCOPUS:85100023289

SN - 0361-8609

VL - 96

SP - E111-E114

JO - American Journal of Hematology

JF - American Journal of Hematology

IS - 4

ER -

Daratumumab in transfusion-dependent patients with low or intermediate-1 risk myelodysplastic syndromes

Access to Document

Other files and links

Cite this